Royalty Pharma PLC (NASDAQ:RPRX)
| 43.03 Delayed Data As of 4:00pm ET |  -0.09 / -0.21%Today’s Change | 34.86 Today|||52-Week Range 44.75 | +7.98% Year-to-Date |
Latest RPRX News | Press Releases
| Royalty Pharma (RPRX) Surges 5.2%: Is This an Indication of Further Gains? Jun 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 43.12 |
| Today’s open | 43.12 |
| Day’s range | 43.00 - 43.58 |
| Volume | 49,067 |
| Average volume (3 months) | 2,152,710 |
| Market cap | $26.0B |
Data as of 4:00pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | -42.47% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +12.42% |
| Revenue growth (last year) | +7.87% |
| P/E ratio | 30.1 |
| Price/Sales | 7.22 |
| Price/Book | 3.20 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.80 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $619.7M |
| Net profit margin | 27.07% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
